View in EDS

Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake.

Saved in:
Bibliographic Details
Title: Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake.
Authors: Klemets A; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Reppo I; Department of Internal Medicine, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.; Internal Medicine Clinic of Tartu University Hospital, Tartu, Estonia., Krigul KL; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Volke V; Department of Internal Medicine, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.; Internal Medicine Clinic of Tartu University Hospital, Tartu, Estonia., Aasmets O; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Org E; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia. elin.org@ut.ee.
Source: Scientific reports [Sci Rep] 2026 Jan 24; Vol. 16 (1), pp. 6126. Date of Electronic Publication: 2026 Jan 24.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2045-2322
DOI:10.1038/s41598-026-36318-3